China Universal Asset Management Co., Ltd. Centessa Pharmaceuticals PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 18,311 shares of CNTA stock, worth $278,327. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,311
Previous 18,909
3.16%
Holding current value
$278,327
Previous $316,000
16.77%
% of portfolio
0.03%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding CNTA
# of Institutions
135Shares Held
123MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$303 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$151 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$147 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$106 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$90 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.43B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...